These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7895361)

  • 1. Altered tissue degradation and distribution of atrial natriuretic peptide in patients with idiopathic dilated cardiomyopathy and its relationship with clinical severity of the disease and sodium handling.
    Iervasi G; Clerico A; Berti S; Pilo A; Biagini A; Bianchi R; Donato L
    Circulation; 1995 Apr; 91(7):2018-27. PubMed ID: 7895361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic study of atrial natriuretic peptide in patients with idiopathic dilated cardiomyopathy: evidence for resistance to biologic effects of the hormone even in patients with mild myocardial involvement.
    Iervasi G; Clerico A; Pilo A; Berti S; Vitek F; Biagini A; Bianchi R; Donato L
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):626-37. PubMed ID: 7528846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANP kinetics in normal men: in vivo measurement by a tracer method and correlation with sodium intake.
    Iervasi G; Clerico A; Berti S; Pilo A; Vitek F; Biagini A; Baratto MT; Bianchi R; Donato L
    Am J Physiol; 1993 Mar; 264(3 Pt 2):F480-9. PubMed ID: 8456961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: how do they relate to the resistance to atrial natriuretic peptides?
    Clerico A; Iervasi G
    J Card Fail; 1995 Sep; 1(4):323-8. PubMed ID: 9420665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans.
    Clerico A; Iervasi G; Berti S; Pilo A; Vitek F; Salvadori S; Marastoni M; Manfredi C; Del Chicca MG; Iascone MR
    J Endocrinol Invest; 1995 Mar; 18(3):194-204. PubMed ID: 7615905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
    Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C
    Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that atrial natriuretic peptide tissue extraction is not changed by large increases in its plasma levels induced by pacing in humans.
    Iervasi G; Clerico A; Pilo A; Vitek F; Berti S; Palmieri C; Ravani M; Sabatino L; Manfredi C; Del Chicca MG; Biagini A; Donato L
    J Clin Endocrinol Metab; 1997 Mar; 82(3):884-8. PubMed ID: 9062501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circulating renin-angiotensin system during treatment with metoprolol or captopril in patients with heart failure due to non-ischaemic dilated cardiomyopathy.
    Jansson K; Dahlström U; Karlberg BE; Karlsson E; Nylander E; Nyquist O; Karlberg KE
    J Intern Med; 1999 May; 245(5):435-43. PubMed ID: 10363743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
    Stevens TL; Burnett JC; Kinoshita M; Matsuda Y; Redfield MM
    J Clin Invest; 1995 Mar; 95(3):1101-8. PubMed ID: 7883958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide and urinary sodium balance during physical exercise.
    De Paoli Vitali E; Malacarne F; Vedovato M; Cavallini R; Bagni B; Nunzi L; Gilli P
    Nephron; 1991; 57(1):60-3. PubMed ID: 1828541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure.
    Molina CR; Fowler MB; McCrory S; Peterson C; Myers BD; Schroeder JS; Murad F
    J Am Coll Cardiol; 1988 Jul; 12(1):175-86. PubMed ID: 2967855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
    Selçuk Y; San A; Bakan E; Yiğitoğlu R
    Nephrol Dial Transplant; 1991; 6(8):557-61. PubMed ID: 1835523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleanolic acid modulates the renin-angiotensin system and cardiac natriuretic hormone concomitantly with volume and pressure balance in rats.
    Ahn YM; Choi YH; Yoon JJ; Lee YJ; Cho KW; Kang DG; Lee HS
    Eur J Pharmacol; 2017 Aug; 809():231-241. PubMed ID: 28514645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hypoxia and atrial natriuretic peptide on aldosterone secretion in healthy subjects.
    Westendorp RG; Roos AN; Simons M; Wertheim W; Bosch FH; Frölich M; Meinders AE
    J Appl Physiol (1985); 1993 Aug; 75(2):534-9. PubMed ID: 8226450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
    Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term and long-term inhibition of endogenous atrial natriuretic peptide in dogs with early-stage heart failure.
    Fukai D; Wada A; Tsutamoto T; Kinoshita M
    Jpn Circ J; 1998 Aug; 62(8):604-10. PubMed ID: 9741739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.